Martin Shkreli has once again been unable to convince a judge to overturn his lifetime pharma industry ban.
Shkreli had attempted to put the ban on hold while he appealed a 2020 conviction regarding his activities related to Daraprim, but judge Denise Cote of the Southern District of New York was not swayed. Cote is the same judge who handed down the original ban in January and upheld it a few weeks later.
‘Shkreli contends once more that the Injunction is overbroad, punitive, and vague,’ Cote wrote in the case.
